Home > Healthcare > Medical Devices > Surgical Devices > Microsurgery Robot Market
Microsurgery Robot Market size was valued at more than USD 1.1 billion in 2022 and is projected to record over 13.5% CAGR from 2023 to 2032. Growing awareness about treatment options for chronic diseases are expected to promote global industry growth.
Mounting cases of chronic diseases including cancer, cardiovascular disease, and gastrointestinal illnesses should drive the deployment of microsurgery robots across healthcare settings. These robots can assist in delivering optimal outcomes and improved patient compliance while treating chronic diseases. Quick healing, decreased surgical complications, improved post-surgical pain management, and shorter hospital stays are some of the factors that have driven the demand for minimally invasive procedures.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Microsurgery Robot Market Size in 2022: | USD 1.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 13.5% |
2032 Value Projection: | USD 4.1 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 225 |
Tables, Charts & Figures: | 207 |
Segments covered: | Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
The high cost of the microsurgery robot would be a key factor hampering microsurgery robots market expansion. Non-reimbursement of some robot-assisted surgical operations is another aspect that could restrict market development. Microsurgery robots are in demand due to the rising number of patients with chronic conditions, but their high price may prevent its widespread use, particularly in low- and middle-income nations. Many people suffering from chronic illnesses are present in developing nations, which makes them reluctant to choose expensive robot-assisted procedures. For instance, the cost of the da Vinci surgical robot, which is utilized in a variety of surgical operations worldwide, is about USD 2 million in the United States.